INTRODUCTION
Recent sttudies on inistulini bindinig have revealed that in the presence of high levels of insulin, various Part of this work has been published in abstract form (CliGu. Res. 23: 109A, 419A, 1975) and presented at the 1975 American Diabetes Association Meetings (Diabetes. 24: 394, 1975 ).
Received for publication 6 Jaitnarn 1976 atnd in revised form 21 September 1976. tissues manifest an impaired ability to bind the hormone. A decreased capacity for binding insulin is found in hepatic tissue from the ob/ob mouse (1) (2) (3) (4) (5) , the db/db mouse (4, 5) , the normal rat given either gold thioglucose (4) or glucocorticoids (6, 7) or harboring a tumor secreting ACTH (8) , and the old obese rat compared to young lean animals (9) ; in monocytes removed from obese humans (10) (11) (12) ; in cultured lymphocytes (13, 14) incubated in vitro in the presence of insulin; in thymocytes (15) and cardiac muscle (16) from the ob/ob mouse; in skeletal muscle from old obese rats compared to young lean animals (17) ; in adipose tissue from obese humans (12, 18) , the ob/ob mouse (19) , rats given a short course of glucocorticoids (7) , and the old obese rat compared to young lean animals (20) . Since high levels of insulin in all of these situations are associated with a decreased capacity for binding the hormone, diminished concentrations of insulin might be expected to enhance insulin binding. The diabetic rat provided an appropriate in vivo model to test this hypothesis.
METHODS
Lewis or Sprague-Dawley rats (200-250 g) were giv-eni streptozotocin (50, 60, or 75 mg/kg) dissolved in citrate buffer (0.01 M, pH 4.0) through the tail vein. Control animals were injected with the buffer alone. Diabetic (streptozotocin) rats were not treated with insulin except for one group injected subcutaneously with 3 U of NPH insulin each moming commencing on the 2nd day after streptozotocin administration. A control group received saline injections concomitantly. The last injection was given on the day before sacrifice. One group of control rats was fasted for 48 h (with free access to water) before sacrifice in an attempt to approximate the diminished weight gain of the diabetic animals.
After 1 wk, the nonfasted animals (except the group starved for 48 h) were sacrificed by decapitation, blood was collected and allowed to clot on ice, and the liver removed. Serum glucose was measured by a glucose oxidase method (Beckman Glucose Analyzer, Beckman Instruments Inc., Fullerton, Calif.) and insulin by a double antibody method (21) At the end of the incubation, a 50-jI aliquot was removed, added to 0.5 ml of 0.1% bovine serum albumin, and precipitated with 0.5 ml of 10% TCA. The mixture was centrifuged and the pellet washed with cold TCA. The pellet was then dissolved in 0.5 ml of 0.5 N NaOH for counting in a gamma well counter. Another 50-,ul aliquot of the original media was incubated overnight with excess anti-insulin antibody and the immuno-precipitated counts determined after addition of normal guinea pig serum and antibody directed against this serum.
Negative cooperativity was assessed in control and diabetic membranes by a modification of the method of De Meyts et al. (26) . After the 150-min incubation period as described under the binding studies, both sets of membranes were each diluted 100-fold with either buffer alone or containing insulin (1 ,ug/ml) at 4°C. Zero time aliquots were processed and the membrane preparations were placed in a shaking water bath maintained at 23°C. Aliquots were removed at appropriate times for filtering and counting.
Glucose-6-phosphatase (27) and 5'-nucleotidase (28) were measured in plasma membrane preparations. There was a 10-fold increase in the activity of the latter enzyme in membrane preparations compared to the homogenates from which they were prepared.
Binding of 125I-glucagon to hepatic plasma membranes was carried out exactly as described by Rodbell et al. (29) assay were compared. To that end, a two-tailed paired t test at each insulin concentration was utilized. In experiments in which binding of hepatic membranes from more than two groups of rats was compared, an analysis of variance was used (30) . Significance for all statistical tests was accepted at the 5% level.
RESULTS
Random plasma glucose and insulin concentrations and weight changes in the control and various diabetic groups of rats studied are shown in Table I . The results from Lewis and Sprague-Dawley animals are combined. Rats were initially rendered diabetic with 75 mg/kg of streptozotocin and compared to control animals (condition 1 vs. 2, Table I ). Control rats gained weight while diabetic animals lost. Glucose concentrations at sacrifice were markedly elevated in the diabetic rats while insulin levels were inappropriately low.
The number of counts of [125I]insulin bound by hepatic plasma membranes prepared from control and diabetic rats is shown in Fig. 1 Scatchard analysis (31) of these same data is depicted in Fig. 2 . The diabetic and control curves are curvilinear and essentially parallel to each other for both the Lewis and Sprague-Dawley rats. This implies that the binding affinities for insulin of the diabetic and control hepatic plasma membranes are similar and that the differences in binding are due to an increased number of insulin receptors in the diabetic liver. Curvilinear Scatchard plots were initially interpreted as representing two classes of insulin receptors (2) . Recent analysis by De Meyts et al. (26) , however, has shown that site to site interactions occur when insulin binds to plasma membranes and the curvilinear shape of the plot is best explained by a negative cooperative effect on one class of binding sites (26) . The diabetic and control hepatic membranes also show negative cooperativity (Fig. 3) . Dissociation of insulin from these hepatic plasma membranes is slower than from LEWIS RATS (Fig. 4) . Note that the amount of insulin bound is plotted on a log scale which reduces the apparent difference between the two curves. As expected from the data in Fig. 1 (34) . Equal activities of 5'-nucleotidase were recovered, however, in fully purified hepatic plasma membranes prepared from diabetic and control Chinese hamsters (35) .
The increased binding of insulin by diabetic membranes is also not explained by a difference in insulin degradation. Intact [125I]insulin was measured by both TCA and antibody precipitability after 2.5 h of incubation in the absence and presence of membranes (Table III) . The results are expressed as the percentage of intact insulin recovered in tubes containing membranes compared to the amount measured in a paired tube without membranes. There is no significant difference in insulin degradation between control and diabetic membranes using either TCA or antibody precipitability to assess the presence of intact insulin.
The specificity of the increased insulin binding by diabetic membranes was evaltuated by measturing the binding of 1251-glucagon to these same membrane preparations (Fig. 5) . Glticagon binding was virttially identical in hepatic plasma membranes prepared from diabetic and control Sprague-Dawley rats.
The effect of varying doses of streptozotocin are shown in fig. 6 . By an analysis of variance, control membranes bound significantly less insulin than membranes prepared from rats treated with 75 mg/kg (P < 0.001) or 60 mg/kg (P < 0.001) of the diabetogenic agent. Insulin binding by hepatic membranes of animals treated with 50 (36) . When diabetic rats were treated with 3 U of NPH insulin per day (Fig. 7) , insulin binding by their hepatic plasma membranes returned to normal and was significantly less than untreated animals (P < 0.02). Glucose concentrations were not diminished by insulin treatment (Table I ,U/ml), but are true measurements of immunoreactive insulin as no insulin antibodies could be detected in the plasma (charcoal-dextran separation of bound and free fractions).
To ascertain that the increased insulin binding by hepatic plasma membranes prepared from these diabetic rats was not secondary to the associated catabolism, four control animals were fasted with free access to water for 48 h before sacrifice. After the fast, these starved rats were 9.8 g less than their original weight. This change is comparable to the 8-15-g weight loss of the severely diabetic rats ( 
DISCUSSION
These data indicate that binding of instulin to hepatic plasma membranes of diabetic rats is increased. Approximately twice as much insulin was bound per unit of hepatic plasma membrane protein in two strains of rats rendered diabetic by streptozotocin (60-75 mg/kg) compared to appropriate controls (Figs.  4 and 6 ). This increased binding of insulin to diabetic membranes was not due to less contamination with other cellular components (Table II) , impaired insulin degradation (Table III) , or slower dissociation of insulin from the membranes (Fig. 3) . Enhanced binding would also not seem to be a nonspecific effect of streptozotocin since insulin binding by rats given 50 mg/kg was not significantly different from controls (Fig. 6) . Furthermore, the catabolic effect of uncontrolled diabetes mellitus is probably not responsible for the difference since control rats starved for 2 days before sacrifice had a similar overall weight loss but significantly less insulin binding than the diabetic animals. Finally, increased binding by diabetic membranes is specific for insulin since glucagon binding was unaltered (Fig. 5) .
Insulin binding in diabetes mellitus has been assessed in several other studies. In one, no difference was demonstrated between binding of insulin to adipocytes from control and streptozotocin diabetic rats (37) . However, no difference could be demonstrated between controls and prednisone-treated animals (37) either. Since adipocytes as well as hepatocytes from dexamethasone-treated rats show decreased insulin binding (6, 7), these negative results must be interpreted with caution. In another study, monocytes harvested from diabetics bound less insulin than cells from either normals or patients with hyperglycemia secondary to pancreatitis (38) . However, fasting insulin Values are expressed as percent of counts (+SEM) precipitated compared to control tubes in which membranes were omitted. concentrations in the diabetics were twice as high as those in both the normal controls and patients with pancreatitis. Thus, increased insulin concentrations probably account for the decreased hormonal binding (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) in these patients. However, purified hepatic plasma membranes from Chinese hamsters (35) and rats2 rendered diabetic with streptozotocin bound approximately twice as much insulin as control membranes, a result in close agreement with our data.
Previous studies in which elevated insulin levels are associated with decreased hormonal binding under a variety of conditions (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) have suggested that the prevailing insulin concentration may itself modulate the number of insulin receptors (13) . The present study supports this postulate. Although the numbers in some of the groups are small, insulin binding seems to correlate inversely with insulin concentrations (Table I) . For instance, rats given 60 and 75 mg/ kg of streptozotocin had significantly lower insulin concentrations at sacrifice (Table I , conditions 2 and 3) than controls and bound significantly more insulin (Figs. 4 and 6 ). Rats given 75 mg/kg of streptozotocin and treated with insulin (Fig. 7) or given 50 mg/kg of streptozotocin (Fig. 6 ) had no decrease in insulin concentrations (Table I , conditions 4 and 5) and no change in instulin binding compared to controls (Figs. 6 and 7) .
In the present study, increased insulin binding associated with the insulinoprivic state of diabetes mellitus was reversed by insulin therapy (Fig. 7) insulin binding by hepatic plasma membranes from the ob/ob mouse (4, 39) , the db/db mouse (4) , and the gold thioglucose rat (4), by adipocytes from the ob/ob mouse (39) and by monocytes from obese human subjects (11) . The enhancement of insulin binding by caloric restriction in the ob/ob mouse can be prevented by administering exogenous insulin during this period (4) . Treatment of the ob/ob mouse with oxytetracycline also decreases insulin levels and increases insulin binding by both hepatic plasma membranes and adipocytes (39) . New Zealand obese mice have increased insulin concentrations and decreased binding by hepatic plasma membranes (33) . Implantation of normal islets of Langerhans into these animals results in normalization of both circulating insulin levels and hormonal binding (33) . Removal of the transplant causes reversal to the original situation, i.e., increased insulin concentrations and decreased binding (33) . Finally, an inverse correlation between insulin concentrations and binding also exists in another insulinoprivic state. Hepatic plasma membranes (40) and thymocytes (41) from hypophysectomized rats (which have decreased plasma insulin levels) demonstrate enhanced insulin binding. Thus, the evidence that insulin can modulate its own receptor seems substantial. Hormone modulation of its specific receptor may be a general phenomenon since high levels of growth hormone (42) , beta-adrenergic catecholamines (43) , and thyrotropin releasing hormone (44) are associated with decreased binding of the respective hormone while conversely the absence of prolactin seems to inhibit activity of its receptor (40) .
The relationship between insulin binding and insulin action seems to be more complex. When both are compared directly on the same tissue, only a small percentage of insulin receptors needs to be occupied to exert a maximal hormonal effect (45) (46) (47) (48) . In addition, there are many situations in which insulin binding and insulin action do not change in parallel. For instance, insulin action is impaired on fat (49), muscle (50) , and liver (51) of diabetic rats but as demonstrated in the present study, insulin binding (at least in the liver) is increased in these animals. Similarly, in caloric deprivation, insulin action is impaired (52-54) while insulin binding is enhanced (4, 53, 54) . In suckling mice (41) and rats fed a high carbohydrate diet (55), insulin activity is increased with no changes in insulin binding. In starved or streptozotocin-treated ob/ob mice, insulin binding increases but the insulin effect on liver and adipose tissue remains markedly diminished (56) .
Therefore, diverse relationships can exist between insulin binding and action: both are decreased in hyperinsulinemic conditions of insulin resistance; both are increased in hypophysectomy; insulin binding is increased while insulin action is impaired in the insulinoprivic states of diabetes mellitus and caloric deprivation; and insulin action is enhanced with no change in insulin binding in both suckling mice (58) . This enhanced binding returned to control levels in both species after 5 days of insulin therapy (58) .
